The COVID-19 Reporting and Data System (CO-RADS) in combination with a CT severity score are easy to use diagnostic tools to guide clinicians in diagnosing COVID-19.
Investigators summarized the evidence on the efficacy and adverse effects of antifungal agents in patients with hematological disease or undergoing hematopoietic stem cell transplantation.
Researchers compared a novel reverse transcription loop-mediated isothermal amplification method to the gold standard, reverse transcription polymerase chain reaction, and assessed the accuracy in detecting SARS-CoV-2.
In hospitalized patients with COVID-19, the routine use of molecular point-of-care testing in emergency department admissions was associated with a large reduction in time to results compared with laboratory PCR testing.
Study authors assessed the specificity and positive predictive value of a customized, institutional, early warning score for predicting decompensation in COVID-19 patients.
Study authors investigated UCP-LF circulating anodic antigen (CAA) as a potential diagnostic test for Schistosoma haematobium in pregnant women.
Point-of-care testing is associated with large reductions in the time to results for patients presenting with suspected COVID-19.
A comparative assessment of 5 immunoassays for SARS-CoV-2 showed that these assays achieved sensitivity and specificity of at least 98%.
In settings where acid-fast bacilli pulmonary diseases are suspected, gastric aspirate culture may be helpful for diagnosing Mycobacterium avium complex and M kansasii pulmonary disease.
The reissued EUA allows for fingerstick blood samples to be tested in point-of-care settings.
Researchers compared 3 immunochromatographic assays (Sienna™, Wondfo®, and Prometheus™) to detect antibodies against SARS-CoV-2 in serum samples, using RT-qPCR as a reference.
There is a low incidence of second PJI in patients with bacteremia or hematogenous periprosthetic joint infection with concomitant prosthetic implants.
Research results highlighted the need for continued supplemental NAATs for oropharyngeal samples being tested for Nisseria gonorrhoeae.
Results are provided within 15 minutes and can be read directly from the testing card.
Neutrophil-to-lymphocyte ratio may be a valuable biomarker to help clinicians recognize severe COVID-19 infection with moderate to severe ARDS.
Routine hepatitis C virus (HCV) testing at federally qualified health centers (FQHCs) would be cost-effective and could improve outcomes for people with HCV infections.
A novel tenofovir urine immunoassay demonstrated predictive utility and may adequately determine PrEP adherence.
By providing bundled HIV and HCV testing, substance use disorder treatment programs may create increased awareness of infection status among people with substance abuse disorders.
A team of researchers performed a systematic review to assess the methodologic quality of studies on the use of chest computed tomographic (CT) imaging in patients with COVID-19 and to determine the frequency of different chest CT findings.
Existing evidence on the diagnostic accuracy of serological tests for COVID-19 is characterized by high risks of bias and heterogeneity.